Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04043169 · ClinicalTrials.gov registry record
Clearblue Pregnancy Test - Lay User Study
A clinical trial of Pregnancy, sponsored by SPD Development Company Limited.
- Completed
- Registry status
- 204
- Enrollment target
- 1
- Study location
NCT04043169: Completed study of Pregnancy, sponsored by SPD Development Company Limited.
NCT04043169 is a study of Pregnancy that has completed, run by SPD Development Company Limited. The registered enrollment target is 204 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04043169, a study of Pregnancy, has completed, sponsored by SPD Development Company Limited.
- COMPLETED
- Registry status
- 204 participants
- Enrollment target
- 1
- Study location
Study Summary
The Clearblue home pregnancy test (HPT) is an over-the-counter urine hCG (human chorionic gonadotropin) integrated digital test which is intended for the detection of pregnancy. This study will assess the performance of a HPT in the hands of lay-users by comparing their results when used according to the instructions for use (IFU) to (i) confirmed pregnancy status of the volunteers and (ii) to the results of trained study staff testing the same urine samples.
Primary Outcome
Number of pregnancy test results in agreement with clinical pregnancy status
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Clearblue pregnancy test
Study Locations (1)
California
- WCCT - Cypress
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2019-07-30 |
| Est. Completion | 2019-12-31 |
What the finished NCT04043169 record still lists
NCT04043169 is an observational study that tracks outcomes without assigning an intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Clearblue pregnancy test is the first listed.
NCT04043169 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04043169 about?
NCT04043169 is a clinical study titled "Clearblue Pregnancy Test - Lay User Study". The Clearblue home pregnancy test (HPT) is an over-the-counter urine hCG (human chorionic gonadotropin) integrated digital test which is intended for the detection of pregnancy. This study will assess the performance of a HPT in the hands of lay-users by comparing their results when used according t...
What is the current status of trial NCT04043169?
This trial is currently completed. The enrollment target is 204 participants. The study started on 2019-07-30. Estimated completion is 2019-12-31.
What conditions does trial NCT04043169 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT04043169?
The interventions under investigation include: Clearblue pregnancy test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04043169?
This trial is sponsored by SPD Development Company Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04043169 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04043169's enrollment target sits among peer trials
204 82nd of 191 higher than 109 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI